Ambrosia bio leverages ginkgo enzyme services to develop a more scalable enzymatic process for allulose

Ambrosia aims to make the production of allulose, a next-generation sugar replacement, more scalable and affordable jerusalem and boston , june 29, 2023  /prnewswire/ -- ambrosia bio, an israeli foodtech company developing novel bioprocesses for the global sugar replacement industry, and ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced that ambrosia bio will leverage ginkgo enzyme services , including its proprietary chassis organisms, to develop an expression strain for the scalable production of the ambrosia bio proprietary enzymes used for the conversion of feedstock into allulose. allulose is an fda-approved rare sugar that is found in figs, raisins, wheat, maple syrup, and molasses but occurs naturally only in small amounts.
DNA Ratings Summary
DNA Quant Ranking